Cargando…
Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do
A commentary on “In vivo CD8(+) T cell CRISPR screening reveals control by Fli1 in infection and cancer”.
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982609/ https://www.ncbi.nlm.nih.gov/pubmed/35693219 http://dx.doi.org/10.1093/pcmedi/pbab015 |
_version_ | 1784681841430626304 |
---|---|
author | Yin, Tao |
author_facet | Yin, Tao |
author_sort | Yin, Tao |
collection | PubMed |
description | A commentary on “In vivo CD8(+) T cell CRISPR screening reveals control by Fli1 in infection and cancer”. |
format | Online Article Text |
id | pubmed-8982609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-89826092022-06-10 Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do Yin, Tao Precis Clin Med Commentary A commentary on “In vivo CD8(+) T cell CRISPR screening reveals control by Fli1 in infection and cancer”. Oxford University Press 2021-07-22 /pmc/articles/PMC8982609/ /pubmed/35693219 http://dx.doi.org/10.1093/pcmedi/pbab015 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the West China School of Medicine & West China Hospital of Sichuan University. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Commentary Yin, Tao Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do |
title | Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do |
title_full | Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do |
title_fullStr | Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do |
title_full_unstemmed | Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do |
title_short | Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do |
title_sort | improving t cell therapy: in vivo crispr-cas9 screens tell us how to do |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982609/ https://www.ncbi.nlm.nih.gov/pubmed/35693219 http://dx.doi.org/10.1093/pcmedi/pbab015 |
work_keys_str_mv | AT yintao improvingtcelltherapyinvivocrisprcas9screenstellushowtodo |